Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECEPT: Panitumumab + FOLFIRI in mCRC
NCT00411450Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 2006
- Primary completion
- Jan 2009
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of panitumumab in metastatic colorectal cancer (mCRC), sponsored by Amgen. Started Nov 2006; status: completed.
02
Drugs
panitumumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00411450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411450.